DNA can be utilized as a generic delivery vector as well as a traditional biological material for DNA vaccination. Although the use of DNA as an antigen expression vector or a vaccine adjuvant has been intensively studied for several decades, the use of DNA molecules as a delivery carrier has not been explored until recently. This issue is probably due to the topological limitation of DNA in its natural linear or circular structure form. Multivalent DNA-based vector delivery platforms overcome this structural barrier and are particularly suited for DNA vaccine delivery because of their multifunctionality, monodispersity, anisotropicity, and bioconjugation ability with numerous functional moieties. In this chapter, we mainly describe the construction of multivalent DNA-based delivery vectors using DNA engineering methods. Specifically, the synthesis strategies for highly branched dendrimer-like DNA structures in general and methods for their application to DNA vaccine delivery are introduced.
DNA Dendrimer-like DNA Drug delivery Anisotropicity Multifunctionality DNA engineering DNA vaccines
This is a preview of subscription content, log in to check access.
Springer Nature is developing a new tool to find and evaluate Protocols. Learn more
Roh YH, Park JH, Ye JJ et al (2012) Systematic studies of UV stability and photopolymerization efficiency of DNA-based nanomaterials. ChemPhysChem 13:2517–2521PubMedCrossRefGoogle Scholar
Zanta MA, Belguise-Valladier P, Behr JP (1999) Gene delivery: a single nuclear localization signal peptide is sufficient to carry DNA to the cell nucleus. Proc Natl Acad Sci U S A 96:91–96PubMedCentralPubMedCrossRefGoogle Scholar
Bonny C, Oberson A, Negri S et al (2001) Cell-permeable peptide inhibitors of JNK: novel blockers of beta-cell death. Diabetes 50:77–82PubMedCrossRefGoogle Scholar
Keller M, Tagawa T, Preuss M et al (2002) Biophysical characterization of the DNA binding and condensing properties of adenoviral core peptide mu. Biochemistry 41:652–659PubMedCrossRefGoogle Scholar
Corbel SY, Rossi FM (2002) Latest developments and in vivo use of the Tet system: ex vivo and in vivo delivery of tetracycline-regulated genes. Curr Opin Biotechnol 13:448–452PubMedCrossRefGoogle Scholar
Mohri K, Nishikawa M, Takahashi N et al (2012) Design and development of nanosized DNA assemblies in polypod-like structures as efficient vehicles for immunostimulatory CpG motifs to immune cells. ACS Nano 6:5931–5940PubMedCrossRefGoogle Scholar